May 2, 2025
Health Law Weekly

Featured Articles

HHS’ Withdrawal of the Richardson Waiver and New Statement of Organization: What Does It Mean for the Health Care Industry?

Career Journeys in Health Tax Law

Emerging Regulatory and Market Trends for Accountable Care Organizations

  • Anthony Del Rio, Kirkland & Ellis LLP
  • Ruan J. Meintjes, Kirkland & Ellis LLP
  • Marie Macaulay, Kirkland & Ellis LLP

Current Topics

Antitrust

Michigan Sues PBMs Alleging Anticompetitive Practices Driving Out Independent Pharmacies

Sutter Health to Pay $228.5 Million to Resolve Long-Running Antitrust Action

Fraud and Compliance

Fourth Circuit Upholds Exclusion of Former Indivior Medical Director from Medicare, Medicaid

Former Lab Execs Sent to Prison for Kickback Conspiracy

Physician Convicted of Unlawful Opioid Distribution

Husband and Wife Plead Guilty to DME False Billing Scheme

Gilead Sciences Agrees to $202 Million Settlement of Speaker Program Allegations

DME Company Owner Found Guilty in Telemedicine Fraud Scheme

Janssen Appeals $1.64 Billion Award in Off-Label Drug Marketing Fraud Action

Rehab Center Agrees to Pay $19.75 Million to Settle Fraud Allegations

Behavioral Health Provider Pleads Guilty to Fraudulently Billing for Autism Services

CMS Touts Successes of Newly Launched Fraud Detection Operations Center

DOJ Files FCA Complaint Against Aetna, Elevance Health, Humana, and Three Insurance Brokers Alleging MA Kickback Scheme

Government Reimbursement

Supreme Court Sides with HHS in Hospitals’ Challenge to Medicare DSH Calculation

Health Law Policy and Administration Hub

Democratic Lawmakers Peg Administration’s Funding Freeze at $430 Billion

Local Governments, Union Sue HHS over Decision to Cut $11 Billion in Public Health Grants

HHS Releases Review of Treatments for Children with Gender Dysphoria

HHS, NIH Launch New Vaccine Platform for Pandemic-Prone Viruses

Life Sciences

U.S. Court in Texas Won’t Enjoin FDA Removal of Semaglutide from Shortage List

Reproductive Health Law Hub

U.S. Court in Texas Allows Generic Manufacturer GenBioPro to Intervene in Abortion Pill Challenge
Current Issue